Take the First Step to Find Long-Lasting Relief for your Bowel Incontinence Symptoms

Axonics Therapy is an effective solution for treating symptoms of bowel (fecal) incontinence, overactive bladder including urinary urgency incontinence, and urinary retention.2.

Bowel incontinence, or accidental bowel leakage, is a condition where people get sudden urges to pass stool and experience leakage of stool before they make it to the restroom.

Bowel Incontinence Symptoms

Bowel incontinence, or accidental bowel leakage, is a condition where people get sudden urges to pass stool and experience leakage of stool before they make it to the restroom.

Axonics Therapy provides gentle stimulation to the nerves that control the bladder and bowel, which can restore normal control and result in symptom improvement.

The Evaluation Step: To see if Axonics Therapy is right for you, you will undergo a short period of therapy using a temporary system. The evaluation period allows you to experience the level of symptom relief the therapy may provide before you commit to long-term therapy.

After a successful trial, you and your physician will decide next steps. Many people choose to proceed with the long-term solution which includes a small, discrete implant that’s placed beneath the skin in the upper part of your buttock.

Clinically Proven. Patient Approved
Backed by clinical studies, Axonics Therapy is clinically proven to regain bowel and bladder control and deliver clinically meaningful improvement in quality of life.

At 2-years:

Doris had suffered with overactive bladder and bowel symptoms since 1987. “The thing that stands out in my mind the most is that this has gone on for so many years and I had to adjust my whole life.” Finally, with Sacral Neuromodulation therapy from Axonics, Doris got her symptoms under control and was able to say “goodbye” to wearing pads!

eady to take the first step towards symptom relief? Schedule a consultation with your doctor to discuss your symptoms and to determine if Axonics Therapy is right for you.

Important Safety Information:

Indications: Axonics SNM Therapy for urinary control is indicated for the treatment of urinary retention and the symptoms of overactive bladder, including urinary urge incontinence and significant symptoms of urgency-frequency alone or in combination, in patients who have failed or could not tolerate more conservative treatments. Axonics SNM Therapy for bowel control is indicated for the treatment of chronic fecal incontinence in patients who have failed or are not candidates for more conservative treatments.

Contraindications: Axonics SNM Therapy is contraindicated for patients who have not demonstrated an appropriate response to test stimulation or patients who are unable to operate the Axonics SNM Systems.

Warnings: Implantation and use of the Axonics Systems incur risks beyond those normally associated with surgery, some of which may necessitate surgical intervention. These risks include, but are not limited to adverse change in voiding function (bowel and/or bladder), infection, pain or irritation at the implant site, lead or device migration, electrical shock, change in sensation or magnitude of stimulation which has been described as uncomfortable (jolting or shocking) by some patients, and heating or burns at the device site.

Results and experiences may vary and are unique to each patient. No promise or guarantee is made about specific results or experiences. Talk to your doctor to see if Axonics Therapy is right for you and to discuss the potential risks and benefits.

For more information about safety and potential risks, go to www.axonics.com/isi.

Precautions: The safety and effectiveness of Axonics Therapy has not been established for use in women who are pregnant or in delivery; for pediatric patients (under the age of 18 years for fecal incontinence and under the age of 16 years for overactive bladder and urinary retention); for patients with neurological diseases, such as multiple sclerosis or diabetes, or for bilateral stimulation.

Caution: U.S. federal law restricts this device to sale and use by, or on the order of, a physician.

1. Ditah I, Devaki P, Luma HN, et al. Prevalence, trends, and risk factors for fecal incontinence in United States adults, 2005-2010. Clin Gastroenterol Hepatol. 2014;12(4):636-43.e432. doi:10.1016/j.cgh.2013.07.020
2. Pezzella A, McCrery R, Lane F, et al. Two‐year outcomes of the ARTISAN‐ SNM study for the treatment of urinary urgency incontinence using the Axonics rechargeable sacral neuromodulation system. Neurourology and Urodynamics. 2021;1–8. https://doi.org/10.1002/nau.24615
3. Jottard K., Van den Broeck S., Komen N., Bruyninx L., De Wachter S. 2021. Treatment of Fecal Incontinence With a Rechargeable Sacral Neuromodulation System: Efficacy, Clinical Outcome, and Ease of Use—Six-Month Follow- Up. Neuromodulation 2021; 24: 1284–1288

©2022 – 2023 Axonics, Inc. All rights reserved. 110-0223-016rB